145 related articles for article (PubMed ID: 35975489)
1. Systematic Infection of Chlamydia Pneumoniae.
Ma Y; Sun J; Che G; Cheng H
Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975489
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immune response associated with Chlamydia pneumoniae infection in atherosclerotic patients.
El Yazouli L; Seghrouchni F; Hejaji H; Bouazza M; Alami AA; Dakka N; Radouani F
Microb Pathog; 2020 Feb; 139():103860. PubMed ID: 31707079
[TBL] [Abstract][Full Text] [Related]
3. Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease.
Droemann D; Rupp J; Goldmann T; Uhlig U; Branscheid D; Vollmer E; Kujath P; Zabel P; Dalhoff K
Am J Respir Crit Care Med; 2007 Apr; 175(8):791-7. PubMed ID: 17290045
[TBL] [Abstract][Full Text] [Related]
4. [Signs of active infection with Chlamydia pneumoniae in patients with coronary heart disease].
Hrubá D; Roubalová K; Kraml P; Andĕl M
Cas Lek Cesk; 2004; 143(12):830-5. PubMed ID: 15730214
[TBL] [Abstract][Full Text] [Related]
5. Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
Hahn DL
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):271-88, 291; quiz 291-2. PubMed ID: 10541419
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer's disease.
Lim C; Hammond CJ; Hingley ST; Balin BJ
J Neuroinflammation; 2014 Dec; 11():217. PubMed ID: 25540075
[TBL] [Abstract][Full Text] [Related]
7. Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease.
Wong YK; Dawkins KD; Ward ME
J Am Coll Cardiol; 1999 Nov; 34(5):1435-9. PubMed ID: 10551689
[TBL] [Abstract][Full Text] [Related]
8. The association of Chlamydia pneumoniae infection with atherosclerosis: Review and update of in vitro and animal studies.
Khoshbayan A; Taheri F; Moghadam MT; Chegini Z; Shariati A
Microb Pathog; 2021 May; 154():104803. PubMed ID: 33609645
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic signs for the inflammatory role of Chlamydia pneumoniae in the high-grade atherosclerotic coronary artery wall.
Legan M; Vraspir-Porenta O; Kese D; Zorc-Pleskovic R; Zorc M
Angiology; 2004; 55(5):525-31. PubMed ID: 15378115
[TBL] [Abstract][Full Text] [Related]
10. Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?
Shima K; Kuhlenbäumer G; Rupp J
Med Microbiol Immunol; 2010 Nov; 199(4):283-9. PubMed ID: 20445987
[TBL] [Abstract][Full Text] [Related]
11. Prior exposure to infection with Chlamydia pneumoniae can influence the T-cell-mediated response to Chlamydia trachomatis.
Telyatnikova N; Hill Gaston JS
FEMS Immunol Med Microbiol; 2006 Jul; 47(2):190-8. PubMed ID: 16831205
[TBL] [Abstract][Full Text] [Related]
12. Nicotine modulates cytokine production by Chlamydia pneumoniae infected human peripheral blood cells.
Mamata Y; Hakki A; Yamamoto Y; Newton C; Klein TW; Pross S; Friedman H
Int Immunopharmacol; 2005 Apr; 5(4):749-56. PubMed ID: 15710343
[TBL] [Abstract][Full Text] [Related]
13. Higher prevalence of Chlamydia pneumoniae seropositivity in Finnish twins compared with co-twins living in Sweden: relationships with markers of subclinical atherosclerosis.
Jartti L; Raitakari OT; Järvisalo MJ; Hammar N; Kaprio J; Koskenvuo M; Marniemi J; Saikku P; Rönnemaa T
Clin Sci (Lond); 2003 Sep; 105(3):303-13. PubMed ID: 12747799
[TBL] [Abstract][Full Text] [Related]
14. Presence and severity of Chlamydia pneumoniae and Cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes.
Liu R; Moroi M; Yamamoto M; Kubota T; Ono T; Funatsu A; Komatsu H; Tsuji T; Hara H; Hara H; Nakamura M; Hirai H; Yamaguchi T
Int Heart J; 2006 Jul; 47(4):511-9. PubMed ID: 16960406
[TBL] [Abstract][Full Text] [Related]
15. Chlamydia pneumoniae infections augment atherosclerotic lesion formation: a role for serum amyloid P.
Ezzahiri R; Stassen FR; Kurvers HR; Dolmans V; Kitslaar PJ; Bruggeman CA
APMIS; 2006 Feb; 114(2):117-26. PubMed ID: 16519748
[TBL] [Abstract][Full Text] [Related]
16. Molecular biology of infectious agents in chronic arthritis.
Gérard HC; Whittum-Hudson JA; Carter JD; Hudson AP
Rheum Dis Clin North Am; 2009 Feb; 35(1):1-19. PubMed ID: 19480994
[TBL] [Abstract][Full Text] [Related]
17. The role of Chlamydia and Chlamydophila infections in reactive arthritis.
Rizzo A; Domenico MD; Carratelli CR; Paolillo R
Intern Med; 2012; 51(1):113-7. PubMed ID: 22214635
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of enzyme linked immunosorbent assays species specific in the detection of Chlamydia trachomatis and Chlamydophila pneumoniae IgG antibodies in patients with genital infections or respiratory tract infections.
Frikha-Gargouri O; Znazen A; Gdoura R; Gargouri B; Arab NB; Jemaa MB; Hammami A
Pathol Biol (Paris); 2008 May; 56(3):143-7. PubMed ID: 18178034
[TBL] [Abstract][Full Text] [Related]
19. Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD.
Brandén E; Koyi H; Gnarpe J; Gnarpe H; Tornling G
Respir Med; 2005 Jan; 99(1):20-6. PubMed ID: 15672844
[TBL] [Abstract][Full Text] [Related]
20. Possibilities for therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in atherosclerosis.
Deniset JF; Pierce GN
Fundam Clin Pharmacol; 2010 Oct; 24(5):607-17. PubMed ID: 20653790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
